Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-Up Study in Patients with Acromegaly Previously Participating in Chiasma Study CH-ACM-01
2015-001292-51Phase 3Completed
- Sponsor
- Chiasma
- Start
- Apr 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of octreotide in acromegaly, sponsored by Chiasma. Primary endpoint: Octreotide capsules treatment outcomes and disease control. Started Apr 2015; status: completed.
02
Drugs
octreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on 2015-001292-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001292-51.